SEC Form 4 · accession 0001140361-15-004403
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Pendarvis
Officer — Chief Administrative Officer
Period of report
Feb 3, 2015
Accepted (ET)
Feb 5, 2015 · 6:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Feb 3, 2015 | M | 5,500 | $25.54 | A | 75,591 | D | |
| ResMed Common Stock | Feb 5, 2015 | S | 5,500 | $62.35 | D | 70,091 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $25.54 | Feb 3, 2015 | M | 5,500 | D | Dec 17, 2010 | Dec 17, 2016 | ResMed Common Stock | 5,500 | 49,585 | D |
Explanation of responses
- F1The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
- F2Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.